Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study
Abstract Background Patients using opioids to treat chronic non-cancer pain often experience side effects that may affect health-related quality of life (HRQOL). These side effects include opioid-induced constipation (OIC), sedation, dizziness, and nausea. OIC can significantly affect HRQOL for pati...
Main Authors: | Michelle S. Keller, Alma Jusufagic, Brennan M. R. Spiegel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12876-019-1097-7 |
Similar Items
-
Management of Constipation in Hospitalized Patients
by: Gregory S. Sayuk, et al.
Published: (2023-09-01) -
Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials
by: Shah ED, et al.
Published: (2023-02-01) -
Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study
by: Akihiro Tokoro, et al.
Published: (2019-08-01) -
Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness
by: Mehta N, et al.
Published: (2023-10-01) -
Potential drug‐induced constipation: A retrospective study using a Japanese claims database
by: Yusuke Karasawa, et al.
Published: (2024-02-01)